Ann: ResAppDx receives regulatory approval in Indonesia, page-25

I not sure about the assumptions. The main reason for USA is that at the time of planning, Australia did not have a break out.

- Better control of how test is conducted
Given the trial is done with people at home, im not sure if this would vary anywhere in the world
- Can instantly modify Algorithm if needed
I dont see how geography has anything to do with timing of data transfer. The subjects need internet no matter where they are an internet is internet
- Have more control of the hospitals used and the patients tested
I recall tests are being sent to people upon requests. I dont think hospitals are involved
- Would be cheaper to run- Results faster and Prof here to oversee
I think main costs are postage and the tests. I cant imagine they differ vastly across th world. India would presumably be cheaper.
- Importantly know what to expect before trialling In other countries

- a bad result will be hard to come back from.

Im pretty comfortable with their approach